AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 287: L730-L742, 2004; doi:10.1152/ajplung.00120.2004
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Paepe, M. E.
Right arrow Articles by Luks, F. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Paepe, M. E.
Right arrow Articles by Luks, F. I.

Fas/FasL-mediated apoptosis in perinatal murine lungs

Monique E. De Paepe,1,2,3 Quanfu Mao,2,3 Michelle Embree-Ku,3 Lewis P. Rubin,1,4,5 and Francois I. Luks1,6

1Program in Fetal Medicine, Departments of 2Pathology and 4Pediatrics, Women and Infants Hospital, Providence 02905; and Departments of 3Pathology and Laboratory Medicine, 5Pediatrics, and 6Surgery, Brown Medical School, Providence, Rhode Island 02905

Submitted 1 April 2004 ; accepted in final form 19 May 2004

Postcanalicular lung development is characterized by a time-specific increase in alveolar epithelial type II cell apoptosis. We have previously demonstrated that, in fetal rabbits, developmental type II cell apoptosis coincides with transient upregulation of the cell death regulator Fas ligand (FasL). The aims of this study were 1) to determine the spatiotemporal patterns of pulmonary apoptosis and Fas/FasL gene expression in the murine model [embryonic day 17 (E17) through postnatal day 5 (P5)], and 2) to investigate the functional involvement of the Fas/FasL system by determining the effect of Fas activation and inhibition on perinatal pulmonary apoptosis. The apoptotic activity of alveolar epithelial type II cells, determined by combined TUNEL labeling and anti-surfactant protein B immunohistochemistry, showed a dramatic increase during the perinatal transition (type II cell apoptotic index <0.1% at E17, 1.5% at P1-P3, and 0.3% at P5). This timing of enhanced type II cell apoptosis coincided with a robust 14-fold increase in Fas mRNA and protein levels and a threefold increase in FasL protein levels; both Fas and FasL immunolocalized to type II and bronchial epithelial cells. In vitro and in vivo exposure of fetal and postnatal murine type II cells to anti-Fas antibody induced a fourfold increase in apoptotic activity that was prevented by administration of a broad-spectrum caspase inhibitor; the pulmonary apoptotic activity of Fas-deficient lpr mice remained unchanged. Conversely, administration of a caspase inhibitor to newborn mice (P1) resulted in marked diminution of pulmonary apoptotic activity. These combined findings strongly implicate the Fas/FasL system as a critical regulator of perinatal type II cell apoptosis. The developmental time dependence of apoptosis-related events in the murine model should facilitate investigations of the regulation of perinatal pulmonary apoptotic gene expression.

programmed cell death; lpr; CD95; lung development



Address for reprint requests and other correspondence: M. E. De Paepe, Women and Infants Hospital, Dept. of Pathology, 101 Dudley St., Providence, RI 02905 (E-mail: mdepaepe{at}wihri.org)




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. E. De Paepe, C. Patel, A. Tsai, S. Gundavarapu, and Q. Mao
Endoglin (CD105) Up-regulation in Pulmonary Microvasculature of Ventilated Preterm Infants
Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 180 - 187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Yi, R. Belcastro, S. Shek, D. Luo, M. Post, and A. K. Tanswell
Fibroblast Growth Factor-2 and Receptor-1{alpha}(IIIc) Regulate Postnatal Rat Lung Cell Apoptosis
Am. J. Respir. Crit. Care Med., September 1, 2006; 174(5): 581 - 589.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Liu, R. Pop, C. Sadegh, C. Brugnara, V. H. Haase, and M. Socolovsky
Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo
Blood, July 1, 2006; 108(1): 123 - 133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. E. De Paepe, Q. Mao, J. Powell, S. E. Rubin, P. DeKoninck, N. Appel, M. Dixon, and F. Gundogan
Growth of Pulmonary Microvasculature in Ventilated Preterm Infants
Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 204 - 211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. E. De Paepe, Q. Mao, Y. Chao, J. L. Powell, L. P. Rubin, and S. Sharma
Hyperoxia-induced apoptosis and Fas/FasL expression in lung epithelial cells
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L647 - L659.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wang and M. You
Five Loci, SLT1 to SLT5, Controlling the Susceptibility to Spontaneously Occurring Lung Cancer in Mice
Cancer Res., September 15, 2005; 65(18): 8158 - 8165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.